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Review Article
Resumo
O derrame parapneumónico caracteriza-se pela ne-
cessidade de um processo invasivo para a sua resolu-
ção e o empiema pela presença de pus na cavidade 
pleural. Em ambos os casos, o diagnóstico por TAC e 
o tratamento precoces resultando em menores morbi-
lidade e mortalidade. São indicação para um trata-
mento invasivo os derrames loculados, os que ocu-
pam mais de 50% do tórax, os que revelam coloração 
por Gram e exame cultural positivos, ou derrames 
com pH inferior a 7,20, glucose inferior a 60 mg/dl, 
e nível de DHL superior a três vezes o limite normal 
no soro. Estas características resultam da evolução 
Abstract
Complicated parapneumonic effusion is one in which 
an invasive procedure is necessary for its resolution 
and empyema means pus in the pleural space. An 
early diagnosis and therapy of these conditions results 
in less morbidity and mortality. CT of the chest is 
important to study complex pleural effusions. Locu-
lated effusions, those occupying more than 50% of 
the thorax, or which show positive Gram stain or 
bacterial culture, or a purulent effusion with a pH 
below 7.20, with a glucose level below 60 mg/dl or a 
LDH level more than three times the upper limit of 
normal for serum, are indications for an invasive pro-
Empiema torácico – Revisão baseada em três casos 
clínicos
Thoracic empyema – A review based on three cases 
reports
Recebido para publicação/received for publication: 08.10.27
Aceite para publicação/accepted for publication: 08.12.16
Antonio Murinello*1
A Manuel Figeiredo*2
Júlio Semedo**3
Helena Damásio*4
N Carrilho Ribeiro***5
Helena Peres****6
1 Chefe de Serviço Graduado de Medicina Interna/Unit Head, Internal Medicine graduate
2 Interno de Especialidade de Medicina Interna/Intern, Internal Medicine
3 Assistente Hospitalar Graduado de Pneumologia/Consultant, Pulmonology graduate
4 Assistente Hospitalar Graduada de Medicina Interna/Consultant, Internal Medicine graduate
5 Director de Serviço de Radiologia/Director, Radiology Unit
6 Assistente Hospitalar Graduada de Patologia Clínica/Unit Consultant, Clinical Pathology graduate
Institutions and units:
* Hospital Curry Cabral – Internal Medicine
** Hospital Pulido Valente – Pneumology
*** Hospital Curry Cabral – Radiology
**** Hospital Curry Cabral – Pathology
R e v i s t a  P o r t u g u e s a  d e  P n e u m o l o g i a508
Vol XV  N.º 3  Maio/Junho  2009
através de três estádios dos derrames incorrectamente 
tratados: 1) exsudativo; 2) fibrino-purulento; 3) fi-
brótico. Dependendo do estádio evolutivo, a aborda-
gem terapêutica varia entra toracentese terapêutica, 
colocação de drenagem torácica com ou sem instila-
ção de fibrinolíticos, cirurgia toracoscópica vídeo-as-
sistida e decorticação pulmonar. Os autores fazem 
uma revisão do estudo destas situações baseados em 
três casos clínicos com apresentações muito díspares: 
uma doente com empiema por Streptococcus pyogenes 
que faleceu rapidamente por hemoptise maciça; um 
doente com empiema resultante de pneumonia agu-
da ocorrida durante um voo de avião; uma doente 
com empiema e bacteriemia por Streptococcus pneu-
moniae conduzindo a diagnóstico até então desco-
nhecido de infecção por VIH.
Rev Port Pneumol 2009; XV (3): 507-519
Palavras-chave: Empiema, derrame parapneumónico, 
Streptococcus pyogenes, pneumococos, VIH, avião.
cedure. These characteristics result from the evolu-
tion of a not well treated parapneumonic effusion, 
through the three stages: (1) exsudative; (2) fibri-
nopurulent; (3) fibrotic. Depending on the stage 
therapeutic methods vary from therapeutic thoracen-
tesis, insertion of a chest tube with or without instil-
lation of fibrinolytics, video-assisted thoracoscopic 
surgery, and lung decortication. A review of all these 
aspects are done based on a series of three cases re-
ports with very different clinical presentation: one 
patient with empyema by Streptococcus pyogenes and 
that died rapidly due to massive hemoptysis; a patient 
with empyema due to acute pneumonia developing 
during an airflight; a patient with empyema and 
bacteraemia by Streptococcus pneumonia leading to 
the diagnosis of an unknown HIV infection.
Rev Port Pneumol 2009; XV (3): 507-519
Key-words: Empyema, parapneumonic effusion, 
Streptococcus pyogenes, pneumococcus, HIV.
Introduction
Parapneumonic effusion occurs in 20-40% 
of patients who are hospitalized with pneu-
monia, the majority of which follow an un-
complicated course responding to isolated 
therapy with antibiotics1. However some 
pleural effusions have a complicated course, 
which means that an invasive process is con-
sidered necessary for its resolution, or that 
its bacterial cultures are positive. Pus in the 
pleural space is named empyema. Delays in 
diagnosis and treatment of these compli-
cated effusions results in increased morbi-
dity, detrimental effect of unresolved sepsis 
and compromised respiratory function on 
quality of life, including loss of livelihood2. 
These considerations emphasizes the need 
for early and if necessary serial chest radio-
graphies to prevent delay in the diagnosis of 
complicated pleural effusions. CT of the 
chest is the imaging study of choice for 
complex fluid collections. Pleural contrast 
enhancement and increased attenuation of 
extrapleural subcostal fat have been asso-
ciated with pleural infection, and absence of 
pleural thickening on CT is more suggestive 
of non-complicated parapneumonic effu-
sion than empyema3.
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Characteristics of effusions that indicate an 
invasive procedure will be necessary for its 
resolution are: an effusion occupying more 
than 50% of the hemithorax or one that is 
loculated; a positive Gram stain or culture of 
the pleural fluid; and a purulent effusion that 
has a pH below 7.20 or a glucose level below 
60 mg/dl, or a LDH level of more than three 
times the upper normal limit for serum4,5.
Considering the therapeutic decisions about 
these effusions several points of manage-
ment shall be considered. If the pleural fluid 
cannot be removed with a therapeutic tho-
racentesis, a chest tube should be inserted 
and consideration be given to the intrapleu-
ral instillation of fibrinolytics. If the locu-
lated effusion persists, the patient should be 
subjected to video-assisted thoracoscopic 
surgery6,7, and if the lung cannot be expan-
ded with this procedure, a full thoracotomy 
with decortication should be performed8,9. 
The definitive procedure should be per-
formed within 14 days5.
Case 1
A 55-year-old white woman was admitted 
to our Unit on the night of 07 FEB 05, after 
a prior evaluation on the Emergency ward 
of our Hospital. She referred chronic de-
pression and hypertension, denying any 
other previous disease and also smoking, al-
coholic and drug addiction, and no risky 
sexual behavior. She began to feel sick one 
week earlier, complaining of slight fever, 
myalgias, odinalgia and hoarseness. Two 
days before admission she complained of 
right pleuritic pain, cough with hemoptoic 
sputum, and increasing dyspnoea on rest. 
She was oriented, had a temperature of 
36.9º C, blood pressure was 164/83 mmHg, 
heart rate 106 bpm, and had a superficial 
respiratory rate of 24 p/mn. She was slightly 
icteric, there was labial herpetic lesions and 
erythema of the oropharynx. Thoracic semio-
 logy was in favour of voluminous right 
pleural effusion, and there was slight he-
patomegaly. Blood LAB tests on the Emer-
gency Ward revealed: no anemia nor throm-
bocytopenia, leucocytes 5.700/mm3 with 
93.6% of neutrophils and 216/mm3 of lym-
phocytes; PCR > 9 mg/dl (<1.0); arterial 
gasometry – pH 7.480, pO2 58.3 mmHg, 
pCO2 27.3 mmHg, HCO3– 20.1 mmol/L, 
O2 sat.. 41.9%; cardiac enzymology was nor-
mal; blood biochemistry: urea 49.8 mg/dl; 
creatinine 1.1 mg/dl; glucose 166 mg/dl; 
normal ionogram, LDH 832 UI/L (313-
618). Electrocardiogram was normal. A vo-
luminous right pleural effusion was demons-
trated on the x-Ray of the thorax (Fig 1A). 
Thoracentesis was realized with drainage of 
750 ml of empyema (Fig 1B). A pleural 
catheter for continuous drainage was not 
inserted. LAB examination of the empyema 
showed: glucose < 10 mg/dl, protein 5.3 g/
dl, many granulocytes and a myriad of 
Gram positive coccus that on culture were 
revealed as Streptococcus pyogenes (Fig 2) sen-
sible to penicillin. Empiric therapy were al-
ready been initiated with e.v. ceftriaxone 
and gentamicin, together with e.v. hydro-
cortisone. At our Unit, 10 hours after pre-
vious drainage on the Emergency Ward, the 
clinical picture was seriously worse, the pa-
tient had accentuated polypnoea and had 
orthopnoea, peripheral cianosis, and tachy-
cardia. The x-Ray of the thorax showed fast 
re-accumulation and worsening of pleural 
fluid effusion (Fig. 1C). She was imme-
diately transferred to the Pneumology Unit 
of the Hospital Stª Marta, where she died 2 
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hours later due to massive haemoptysis. 
Necropsy was not authorized by his family. 
Several days later the Pathology Department 
detected a co-existent positive culture of 
pleural effusion with a non-identified atypi-
cal Mycobacteria. The HIV status of the pa-
tient was unknown.
Comment
Invasive group A Streptococcus infections oc-
cur rarely but are serious, and can manifest 
as streptococcal toxic shock syndrome, soft-
tissue infections (fasciitis, myositis, celluli-
tis, erysipelas), bacteraemia, pneumonia, 
peritonsilar or retropharyngeal abscess, si-
nusitis. In addition to suppurative compli-
cations, nonsuppurative complications can 
also occur, as acute rheumatic fever, post-
streptococcal glomerulonephritis, central 
nervous system diseases10. The main viru-
lence factor of the group A streptococcus is 
the cell wall M-protein that inhibits com-
plement activation and decreases phagocy-
tosis11.
Streptococcus pyogenes is an uncommon cause 
of community-acquired pneumonia (CAP) 
that sometimes occurs as a secondary infec-
tion following acute viral infections (meas-
les, influenza, varicella) or bacterial infec-
tions as by H. pertussis in COPD patients, 
or after streptococcal pharyngitis. Entry of 
the microorganism into the lung usually re-
sults from inhalation or microaspiration. 
Rarely, streptococcal pneumonia is due to 
hematogenous seeding from other infected 
sites11. In the pre-antibiotic era epidemic 
streptococcal pneumonia was more fre-
quent, occurring in institutions where close 
contact predisposed to transmissibility, as 
for example in military recruit populations12 
or in nursing homes. Most recent series re-
port a high frequency of association of sig-
Fig. 1 – A – PA view of thorax X-ray at admission; B – PA view of thorax X-ray after drainage of 750 ml of pus; C – PA view 
of thorax X-ray – 10 hours after previous drainage of pus
A B C
Fig. 2 – Gram stain: innumerous Gram + coccus in the pus, 
identifi ed by culture as Streptococcus pyogenes
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nificant chronic illness (chronic lung di-
sease, cardiac disease, cancer, alcohol abuse, 
diabetes mellitus, intravenous drug use, re-
nal impairment, cirrhosis, HIV infection, 
systemic lupus erythematosus, organ trans-
plant recipients)13.
The presenting clinical features of Strepto-
coccus pyogenes pneumonia are usually high 
fever, chills, sore throat, cough and fre-
quently purulent sputum, pleuritic pain, 
rapid onset of dyspnoea, and sometimes he-
moptysis. Myalgias, confusion, meningeal 
signs and a widespread rash (“purpura ful-
minans”) may occur14. The most typical fea-
ture suggesting this diagnosis, however, is 
the rapid accumulation of a pleural empye-
ma (“explosive pleuritis”) in a patient pre-
senting with acute respiratory infection 
(80% of the cases), and that rapidly prog-
ress to loculated empyema. Pleural empye-
mas due to group A beta-hemolytic strepto-
cocci is uncommon in the antibiotic era, 
although more frequent in children and 
neonate15,16. In adults it has not been widely 
reported except for some reviews and case 
reports11,17. Streptococcus pyogenes has singled 
out as the case of small pneumonia with ex-
tensive empyema18.
Other complications of Streptococcus pyo-
genes pneumonia are necrotizing pneumo-
nia leading to lung abscess and extending 
infection, pneumatocele, pneumothorax, 
bronchopleural fistula and more uncom-
monly pericarditis, osteomyelitis, metastatic 
abscesses, septicaemia and shock17. A rare 
and serious complication is hypertensive 
pyopneumothorax19.
These pneumonias have potentially high 
mortality and have a slow response to anti-
biotic therapy. Even with urgent drainage of 
empyemas by chest tube the evolution is 
many times dismal, with a case fatality rate 
of 30 to 60% of the cases depending on the 
series, occurring more commonly in pa-
tients with bacteraemia. The progression of 
fatal cases is generally rapid, with a median 
time to death of 2 days, even in the absence 
of underlying medical conditions14.
Hemoptysis is a significant and frightening 
clinical presentation of some respiratory 
diseases. Although massive hemoptysis ac-
counts for a minority of all patients with 
hemoptysis, it is a major challenge for treat-
ment. Massive hemoptysis has been variably 
defined as expectoration of 100 to more 
than 1000 ml of blood in 24 to 48 
hours20,21,22. Although rare, it is a potentially 
lethal condition due to asphyxia and airway 
obstruction, shock and exsanguinations. 
When untreated it has a mortality rate of 
> 50%23, so deserving appropriate and 
prompt therapeutic intervention.
In the general population, the commonest 
causes of massive hemoptysis are bron-
chiectasis and lung infections, including tu-
berculosis, lung abscess and aspergilloma24. 
Other causes of massive hemoptysis are lung 
cancer, emphysema, collagen vascular di-
sease22. Aiyappan25 referred a case of massive 
hemoptysis in a intravenous drug user on 
anticoagulants for deep vein thrombosis, 
with necropsy revealing the presence of 
bronchiectasis and pulmonary infection. 
On a high number of patients with massive 
hemoptysis it is not possible to find under-
lying pathology to explain the cause of the 
hemorrhage, and these cases are referred as 
“pulmonary hemorrhage syndrome”26.
We found only two references of massive 
pulmonary hemorrhage associated with 
Streptococcal pyogenes pulmonary infection, 
both in very young children. In one of the 
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cases necropsy revealed the presence of nu-
merous cocci in the vessels and massive pul-
monary hemorrhage and isolation of group 
A Streptococcus pyogenes from the blood (type 
M4, T4, which produces exotoxin type B 
and C)27. The other case presented with 
cardio-respiratory failure and massive he-
moptysis and, besides an inoperable me-
diastinal vascular tumor, autopsy revealed 
mycotic aneurysm of the superior bronchial 
artery28.
On our patient the refusal of the family of 
the patient to accept necropsy resulted on 
the impossibility to know the cause of the 
massive hemoptysis. The low number of 
lymphocytes and the positive culture of 
pleural empyema for an atypical Mycobacte-
ria was in favor of a hypothetical severe de-
gree of previously immunodeficiency of un-
known etiology. We think that this was a 
rational basis to accept a cause and effect re-
lationship between the pleuropulmonary 
infection and the fulminant hemoptysis.
The therapeutic approach to massive he-
moptysis implies urgent resuscitation, 
prompt diagnostic lateralization of the etio-
logic lesion and surgical resection if an-
gioembolization of the pathologic bleeding 
arterial vessels will be not efficacious29,30,31,32 
. Unfortunately to our patient the extremely 
rapid worsening of the situation did not 
permit to proceed to any salvage therapeutic 
attitude.
Case 2
A 53-year-old white man with antecedents 
of bariatric surgery for morbid obesity in 
2000 and cholecystectomy and liver fibrosis 
of unknown etiology was admitted on MAR 
07 to our Unit, with a diagnosis of CAP 
with associated parapneumonic pleural ef-
fusion. The patient was an entrepreneur 
with business in Angola (Western Africa) 
and he had taken a plane to Angola already 
complaining of symptoms of upper respira-
tory viral infection lasting for four days. 
During the flight he suddenly feel rigors, 
fever (38º C), right pleuritic pain and cough 
with mucoid sputum, that turned purulent 
on the subsequent days, together with in-
creasing dyspnoea of effort. The symptoma-
tology did not recede with azithromycin. 
He came back to Portugal after 5 days, and 
was assisted on the day of arrival in Portugal 
on the Emergency Ward of our Hospital. 
Physical examination was in favour of acute 
pneumonia of right lower lobe with asso-
ciated right pleural effusion. LAB tests re-
vealed: no anemia nor thrombocytopenia, 
leucocytosis (17.700/mm3) with neutro-
philia (88%), PCR 24 mg/dl, normal blood 
biochemistry except high values of alkaline 
phosphatase 262 UI/L(38-126) and γ-GT 
294 UI/L(15-73). The x-Ray of the thorax 
showed acute infection of the right lower 
lobe and associated voluminous pleural ef-
fusion (Fig 3). A diagnostic thoracentesis 
revealed serohematic pleural fluid, with low 
level of glucose (< 10 mg/dl), high level of 
protein (5.8 g/dl) and of LDH (4.600 U/L), 
and high number of granulocytes (total leu-
cocytes 2.2×109/L with 98.5% neutrophils). 
He was treated empirically with e.v. ceftri-
axone and clarithromycin. A first CT scan 
realized 48 hrs after admission revealed al-
ready some degree of loculation and an al-
veolar infiltrate of the lower lobe. It was de-
cided to insert a pleurocatheter. However 
the degree of drainage was not enough to 
satisfying resolute the pleural effusion, pleu-
ral adhesions being then more exuberant, 
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chanism of permanent exhausting some vo-
lume of re-circulating cabin air is also work-
ing. It is also necessary to consider that 
cabin air circulating unintentionally through 
the cabin envelope can induce a number of 
adverse effects: condensation, corrosion, 
microbials, fire toxic gases33.
Respiratory infections related to air travel is 
more usual during pandemics and during 
cold weather flu, cold and sore throat sea-
son. It is very common for air passengers 
suffering a sore throat or worse a few days 
associated with parenchymal necrosis and 
loculation of fluid, as was demonstrated by 
another CT scan 10 days later (Fig. 4). The 
patient was transferred to the Unit of Car-
dio-Thoracic Surgery of the Hospital Pulido 
Valente. She was submitted to surgical deco-
rtication of the lung and atypical resection 
of the right lower lobe. No one of the col-
lected fluid samples, the first before surgery 
and the second during surgery, gave a posi-
tive result on cultural bacteriologic studies, 
but the patient was already taking antibio-
tics before sampling. The material examined 
at the Pathology Department was compati-
ble with empyema. After surgery the patient 
initiated a program of respiratory kinesi-
therapy, referring progressive amelioration.
Comment
On a report about Aircraft Cabin Air 
Health, Safety and Confort Challenges, 
Walkinshaw 33 called attention to the higher 
frequency of occurrence of respiratory sys-
tem infections on aircraft passengers, due to 
several factors common in aircraft ambient: 
(1) high occupancy density (mostly on 
economy class); (2) wide range of occupant 
ages; (3) health conditions of the aircraft oc-
cupants; (4) activities in the aircraft during 
the flight; (5) pathogen strains in the envi-
ronment.
A high quality and good functioning of the 
aircraft environment control systems of air 
recirculation is very important. The air in 
an aircraft cabin is a mixture of outside air 
entering the cabin (50%) and re-circulated 
air existent in the cabin (50%), both having 
to pass through filters. The filters have to 
remove volatile organic compounds, dust, 
smoke particles, bacteria and virus. A me-
Fig. 3 – PA view of thorax X-ray showing voluminous right 
pleural effusion
Fig. 4 – CT scan revealing loculation of the empyema
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after a flying. In fact, high microbial/viral 
airborne concentrations were demonstrated 
in aircraft cabins33.
Factors to consider responsible for the 
spread of respiratory infections in passen-
gers aircraft are: (1) air circulation patterns 
and close seating proximity spreads patho-
gens between people in the same and several 
nearby rows, (2) multi-city and internation-
al travels increase risk, (3) high cabin occu-
pancy density and low ventilation rate in-
crease risk, (4) low humidity increase the 
risk33.
The volume of air surrounding an office 
worker is typically 30 times that surround-
ing the occupant of a passenger aircraft. 
Classroom occupancy density is 10 times 
lower than in aircraft. The occupancy den-
sity in a cabin aircraft results in higher per-
centage of bioeffluents (gases, pathogens). 
Also the environmental control systems air 
delivery circulation flows cause air to circu-
late between occupants in the same row and 
in nearly rows. This circulation, plus low 
humidity that is more common during lon-
ger airflights, may be the main factors in the 
higher than “normal” upper respiratory in-
fections33.
Our patient was already sick, presumably 
with only an upper respiratory infection, 
but become much sicker during a long air-
flight, with development of pneumonia and 
complicated parapneumonic pleural effu-
sion with evolution to empyema, being nec-
essary to proceed to lung decortication for 
the resolution of the process.
Case 3
A 35-year-old white woman was admitted 
on 08 MAR 24 with a diagnosis of CAP 
with parapneumonic pleural effusion. For 
one month she had a fluctuant course of 
cough, hoarseness, nasal stuffiness and pu-
rulent non bloody sputum, partially alle-
viated with two short cycles of antibiotics. 
Three days before admission she com-
plained of right pleuritic pain, tiredness 
and spiking fever (T 38.4 ºC). She was on 
thyroid replacement therapy due to hemith-
yroidectomy for a toxic adenoma 3 years 
ago. Physical examination showed no signs 
of respiratory failure and no haemodynam-
ic compromise. Thoracic respiratory semio-
logy was in favour of pneumonia of the 
right lower lobe and possible pleural effu-
sion. At the Emergency Ward LAB tests re-
vealed: slight normocytic normochromic 
anemia (Hb 10 g/dl), leucopenia (3.700/
mm3 with 87.5% neutrophils) and lym-
phopenia (451/mm3), no thrombocytope-
nia, PCR 27 mg/dl, and normal biochemis-
try. The x-Ray of the thorax revealed 
moderate right pleural effusion. Empiric 
therapy was initiated with e.v. ceftriaxone 
and clarithromycin after collection of three 
blood cultures, that later on revealed bacte-
raemia by Streptococcus pneumoniae sensible 
to penicillin. Sputum culture was also posi-
tive for Streptococcus pneumonia. In our 
Unit she referred to have been separated for 
sometime from her husband, and mean-
while both of them had other se xual part-
ners. At admission her CD4 count was 
145/mm3 and she had positive serology for 
HIV 1, with a viral charge of 2.132 co pies/
ml (3.33 Log 10). After several days, pleu-
ral effusion worsened (Fig 5). Thoracentesis 
drained purulent fluid with plenty of gran-
ulocytes and negative bacteriologic culture. 
CT scan of the thorax revealed voluminous 
right pleural empyema with two areas of 
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loculation (Fig. 6A), bronchiectasis of seg-
mentary branches of the middle lobe and a 
lung abscess of the same lobe (Fig 6B). We 
proceeded to thoracic US-guided pleural 
fluid drainage by pleural catheter, after 
which the patient progressively ameliorated 
(Fig. 7), with discharge after 21 days of an-
tibiotic therapy. At that time CD4 count 
were higher: 297/mm3. She continued chest 
kinesitherapy in ambulatory and initiated 
HART for HIV 1 infection with efavirenz, 
emtricitabine and tenofovir.
Comment
Bacterial respiratory infections, including 
infectious airways disease and pneumonia, 
currently account for most pulmonary in-
fections diagnosed in HIV-infected indi-
viduals34. Two or more episodes of bacterial 
pneumonia within a 1-year period is con-
sidered an AIDS-defining illness in a HIV-
infected patient, regardless of the CD4 cell 
count35. Besides altered cell-mediated im-
munity in HIV-infected patients, additional 
immune deficits may occur, such as poor 
antibody response due to B cell dysfunction 
and defects in chemotaxis, phagocytosis, 
and intracellular killing by monocytes, ma-
crophages, and neutrophils36. Impairment 
of local defenses, expressed in depression 
of specific IgA at the mucosal surfaces, is 
another common occurrence. In HIV-in-
fected patients all these immune abnormali-
ties contribute to an increased risk of bacte-
rial infection, mostly by encapsulated 
bacteria Streptococcus pneumoniae and Hae-
mophilus influenza.
Fig. 5 – PA view of thorax X-ray showing voluminous right 
pleural effusion and discrete densifi cations of the left lung
Fig. 6 – A – CT scan showing two areas of loculation of empyema; B – CT scan revealing lung abscess of the right middle lobe
A B
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The incidence of CAP in HIV-infected pa-
tients is six times greater than in the general 
population37. Depending on the degree of 
immune suppression different microorga-
nisms occur with variable frequency. Al-
though the risk of bacterial pneumonia in-
creases steadily with declining CD4 counts, 
bacterial pneumonia often occurs in the 
early stages of HIV infection. At the initial 
stages of infection and besides the above re-
ferred encapsulated microorganisms, we 
have to consider Staphylococcus aureus, Es-
cherichia coli, and Pseudomonas aeruginosa. 
Atypical agents such as Legionella pneumo-
phila and Mycoplasma pneumoniae are not 
common agents in CAP in HIV patients 38.
Pleural effusion due to bacterial pneumonia 
occurs in greater rate in HIV patients than 
patients without HIV infection39. Also in 
HIV patients the clinical course is more se-
vere, pleural fluid has a lower glucose level, 
there is generally a higher rate of concomi-
tant bacteraemia (60% versus 15-30%) and 
positive pleural cultures, and a greater need 
for chest tube drainage. Bronchopleural fis-
tula is also more frequent in these pa-
tients40.
Depending on the type of HIV population 
the most common isolated agent from pleu-
ral fluid is Streptococcus pneumonia or Staph-
ylococcus aureus (in parenteral drug abu-
sers)41. Patients with HIV infection have an 
increased propensity for developing thoracic 
complex empyemas secondary to their sus-
ceptibility to polymicrobial pulmonary in-
fections, including anaerobes40,41, and as a 
consequence results of therapy with video-
assisted thoracic surgery are not so favorable 
as in patients without HIV infection. There-
fore these patients often required surgery 
with lung resection, which necessitated lon-
ger periods of postoperative chest tube 
drainage41. HIV-infected individuals with 
advanced immunosuppression are also at 
risk for a variety of unusual organisms, in-
cluding R. equi, N. asteroids, B. henselae and 
B. quintana34.
On our patient the existence of leucopenia 
at admission in a clinical picture of acute 
pneumonia lead us to suspect of coexistent 
infection by HIV, which was confirmed by 
positive serology. Bacteraemia and the com-
plicated evolution of the parapneumonic 
pleural fluid in our patient was in accor-
dance with the already known difficulties in 
therapeutic responses, that patients with 
HIV infection usually present due to mul-
tiple immunologic abnormalities.
Final discussion
The presentation of empyema can vary from 
nonspecific constitutional, symptoms to 
fulminant sepsis. Long delays in diagnosis 
result in delays in treatment, leading to de-
creased pulmonary function and local and 
systemic sequelae of active, ongoing infec-
tion. Early chest tube placement is impor-
Fig. 7 – CT scan of the thorax revealing amelioration of the 
infectious process
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tant to establish a route for drainage43, but 
often it is not a definitive measure. Ash-
baugh44 refers in a review that delay in chest 
tube drainage increased the mortality rate 
from 3.4 to 16 per cent.
Parapneumonic effusions can have an evo-
lution of a continuous spectrum of abnor-
malities subdivided into three stages: 1) – 
the exsudative stage, characterized by rapid 
outpouring of sterile fluid into the pleural 
space, that without timely correct treatment 
may proceed in a few days to 2) – the fibri-
nopurulent stage, in which extensive pleural 
infection decreases glucose level to values 
below 60 mg/dl, increases LDH to more 
than three times the upper normal limit for 
serum, pH is below 7.20 and there is high 
number of granulocytes. In this stage, the 
pleural fluid becomes progressively locula-
ted. The effusion needs to be drained, and 
this becomes progressively difficult as more 
loculations form. Video-assisted thoracos-
copic surgery is indicated to multiloculated 
empyema. If this is not done in due time the 
effusions may progress to 3) – the fibrotic 
stage, in which fibroblasts grow into the 
pleural fluid from both the visceral and pa-
rietal pleura, producing a thick pleural peel. 
The peel over the visceral pleura encases the 
lung and prevents it from expanding5. Be-
cause the pleural space must be eradicated if 
a pleural infection is going to be eliminated, 
this peel must be removed by decortica-
tion45,46.
Thoracic empyema is a progressive process 
that does not undergo spontaneous resolu-
tion. Chronic empyema occurs when this 
proceed is allowed to evolve for 4 to 6 weeks 
without adequate treatment, consolidating 
into a thick fibrous peel that covers and en-
traps the lung. Complications of chronic 
empyema include costochondritis and os-
teomyelitis of the ribs, bronchopleural fis-
tula, pericarditis, pulmonary and mediasti-
nal abscesses, or disseminated infection9.
On our Unit of Internal Medicine empyema 
is an entity rarely diagnosed, with an occur-
rence not surpassing one to two cases yearly. 
The admission of three cases in a year with 
so disparate and important characteristics, 
that we think can be useful to compare with 
cases of other patients in medical bibliogra-
phy, prompted us to report these cases.
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